Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-058694

Director bought 67,881 shares at an average $1.02 ($69,233)

From the SEC's structured data for this filing

Trades in this filing

Lamond David · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-12 Purchase : show line 1 in the form +300 $1.00 $300 2,279,964 I
2023-12-12 Purchase : show line 2 in the form +22,327 $1.02 $22,774 2,302,291 D
2023-12-13 Purchase : show line 3 in the form +22,627 $1.00 $22,627 2,324,918 I
2023-12-14 Purchase : show line 4 in the form +22,627 $1.04 $23,532 2,347,545 I
Open-market purchases · 67,881 sh · avg $1.02 · $69,233
Loading xslF345X05/doc4.xml…